L. Dracea (Brasov, Romania), J. Morton (Randwick, Australia)
Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis
E. J. Faria, A. E. Alvarez, J. D. Ribeiro, A. F. Ribeiro, C. S. Bertuzzo (Campinas, Brazil)
|  |
Is mitochondria morphology altered in epithelial cells with cystic fibrosis?
Y. Tourneur, S. Recher, F. Gaden, P. Boulanger, C. Paulin, G. Bellon, Y. Pacheco (Pierre-Benite, Lyon, France)
| |
Twelve months experience with azithromycin in children with deteriorating CF lung disease
J. R. Morton, Y. Belessis, P. Field (Randwick, Australia)
| |
Pulmonary adaptations during exercise in CF
W. Gruber, D. Kiosz, K. Paul (Amrum, Germany)
| |
Efficacy of non-invasive positive pressure ventilation (NIPPV) in cystic fibrosis (CF) patients with acute respiratory failure (ARF)
V. A. Samoilenko, M. A. Koutsenko, A. G. Chuchalin (Moscow, Russia)
| |
Time course of inspiratory muscle performance in patients with cystic fibrosis and severe airway obstruction
C. Braggion, L. Menin, P. Benedetti, U. Pradal, M. Ocampo, B. M. Assael (Verona, Italy)
| |
Gender comparisons of body composition, inspiratory muscle function and diaphragm thickness in adult patients with cystic fibrosis
S. J. Enright, V. B. Unnithan (Salford, United Kingdom; Syracuse, United States Of America)
| |
Genotype and progressive lung damage in adult cystic fibrosis patients
F. A. Mata, J. De Gracia, A. Alvarez, D. de la Rosa, M. Culebras (Barcelona, Spain)
| |
Are gastrostomies useful in CF?
R. Jayaram, H. Vaindirlis, T. Salerno, M. Rosenthal, A. Bush (London, United Kingdom)
| |
Anthropometric differences in Lithuanian children with CF and other obstructive lung diseases
I. Skurvydiene, L. I. Indrejaityte, A. Valiulis (Taurage, Vilnius, Lithuania)
| |
Experience with totally implantable venous access devices in cystic fibrosis patients
E. Eber, B. Oberwaldner, D. Dacar, M. S. Zach (Graz, Austria)
| |
Eradication of pseudomonas aeruginosa in paediatric cystic fibrosis patients in Northern Ireland
B. O Connor, N. A. Henderson, A. Reid, J. McCaughan (Belfast, United Kingdom)
| |
Burkholderia cepacia complex infection in Czech patients with cystic fibrosis
P. Drevinek, O. Cinek, J. Bartosova, D. Zemkova, P. Pohunek, V. Vavrova (Prague, Czech Republic)
| |
Phenotypic assessment of potential Burkholderia cepacia virulence associated determinants
A. De Soyza, J. Perry, C. M. A. Khan, P. A. Corris (Newcastle, United Kingdom)
| |
Effect of high dose tobramicin (TOBI®) inhalation on respiratory values in cystic fibrosis
D. Costantini, A. Brivio, D. Brusa, E. Bucchioni, C. Colombo (Milan, Italy)
| |
Phenotypic and genotypic profiles of microorganisms isolated from children with cystic fibrosis
H. Dmenska, K. Semczuk, M. Modrzewska, D. Dzierzanowska (Warsaw, Poland)
| |
Relationships between bronchodilator therapy, resting energy expenditure and systemic inflammation in cystic fibrosis
A. A. Ionescu, L. S. Nixon, C. E. Bolton, D. J. Shale (Cardiff, United Kingdom)
| |